Grupo Español Multidisciplinar De Melanoma
Clinical trials sponsored by Grupo Español Multidisciplinar De Melanoma, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to tackle melanoma that resists treatment Results expected Jun 2027 (estimated)
-
New drug shows promise against rare eye cancer before liver surgery
Disease control Recruiting nowThis phase 2 trial is testing a drug called tebentafusp in 19 people with a rare eye cancer (uveal melanoma) that has spread to the liver. Participants receive weekly infusions for 6 months, then may have surgery to remove any remaining tumors. The goal is to see if the drug can …
Phase 2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New hope for melanoma brain metastases: Two-Step treatment trial launches
Disease control Recruiting nowThis phase 2 trial is testing a two-step treatment for people with BRAF-mutated melanoma that has spread to the brain and is causing symptoms. First, participants take two targeted pills (encorafenib and binimetinib) for about two months. Then, they receive two immunotherapy drug…
Phase 2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC